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Trachoma is the leading cause of infectious blindness worldwide. The SAFE strategy, the World Health Organization-recommended
method to eliminate blinding trachoma, combines developments in water, sanitation, surgery, and antibiotic treatment. Current
literature does not focus on the comprehensive effect these components have on one another. The present systematic review analyzes
the added benefit of water, sanitation, and hygiene education interventions to preventive mass drug administration of azithromycin
for trachoma. Trials were identified from the PubMed database using a series of search terms. Three studies met the complete
criteria for inclusion. Though all studies found a significant change in reduction of active trachoma prevalence, the research is still
too limited to suggest the impact of the “F” and “E” components on trachoma prevalence and ultimately its effects on blindness.

1. Introduction
Caused by the bacteria Chlamydia trachomatis, trachoma is
the world’s leading cause of infectious blindness [1]. Associated with a lack of access to water, sanitation, and hygiene
education (WASH), trachoma debilitates some of the world’s
most marginalized peoples [2]. The World Health Organization (WHO) estimates that 325 million people in 53 countries
live in trachoma-endemic areas [3]. The routes of transmission of trachoma, all of which are hygiene related, include
indirect infection by fly vector as well as direct person-toperson and indirect contacts via fomites including clothing,
towels, and handkerchiefs [3]. Blindness due to trachoma
is caused by repeated infection of Chlamydia trachomatis
resulting in the inflammation of the upper eyelid, which
eventually leads to scarring. Scarring, over time, constricts
the upper lid causing the eye lashes to pull inward, scratching,
and tearing the cornea resulting in loss of vision [4, 5].
Trachoma has caused visual impairment in 2.2 million people
globally of which 1.2 million endure irreversible blindness [3].

The WHO strategy to eliminate all avoidable blindness
by the year 2020 is called VISION 2020: Right to Sight.
Blinding trachoma as a public health problem is specifically
targeted as a priority condition in this initiative through an
alliance of partners working with WHO called the Global
Elimination of Trachoma as a Cause of Blindness by the
Year 2020 (GET 2020) [4]. These collaborators work toward
eliminating trachoma-related blindness through the implementation of an integrated intervention called the SAFE
strategy (surgery, antibiotic, face washing, and environmental
control); it is a multifaceted methodical initiative attempting
to stop all levels of disease transmission and eliminate its
reoccurrence [16]. The SAFE strategy includes the following:
prevention of blindness by treating end-stage trachoma
through surgery; reduction of the reservoir of infection by
distributing antibiotics such as azithromycin; and removal of
risk factors that encourage transmission of infection through
facial cleanliness and environmental changes [17].
The “A”, “F,” and “E” components of the SAFE strategy
focus on the reduction of disease transmission. Because
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active trachoma clusters in households or social groups,
infection control should consist of community-based efforts
to interrupt transmission as evidenced through the WHOrecommended mass antibiotic treatment of an entire district
population annually for three years or more if active trachoma prevalence is above 10% [18]. Due to the inclusive
nature of MDA programs, they are successful in reducing
the prevalence of infection, slowing trachoma transmission
and making it more manageable by WASH components to
decrease the likelihood of reemergence as a public-health
problem [19]. Before azithromycin, an ingestible antibiotic,
for trachoma control, tetracycline eye ointment was used as
the antibiotic component of the SAFE strategy [20]. Tetracycline compliance, and therefore effectiveness, was affected
by its tedious application process, twice a day for six weeks
[21]. Azithromycin treatments are easily administered by
community control programs through height-based dosing
and are considered by some to be the closest to the perfect
antibacterial for MDA [22, 23].
In the following research, a systematic review was conducted to look a step beyond the impact of the A, F, and E
components on the overall prevalence of trachoma and focus
on the added value of WASH interventions, specifically the
components “F” and “E” of the SAFE strategy, on the “A”
component.

2. Methodology
2.1. Search Strategy and Initial Selection Criteria. A systematic
search and review of articles was conducted using the Metaanalysis of Observational Studies in Epidemiology (MOOSE)
as a guideline [24]. PubMed, Lista, EBSCO, and MEDLINE
databases were searched using key words pairing water, sanitation, and hygiene education against trachoma and either
preventive chemotherapy, mass chemotherapy, or antibiotic.
No restrictions were put on study date, location, design, or
language of publication. The final search was conducted on
March 20, 2013.
The primary outcome measure for this review was
prevalence of active trachoma measured as the number of
participants with trachomatis inflammation follicular (TF)
and/or trachomatis inflammation intense (TI) before and
after intervention. Active trachoma was identified by the
WHO trachoma grading scale and/or diagnostic swab testing
for ocular Chlamydia infection [25]. Secondary outcomes
included changes in knowledge, attitudes, and practice specific to the risk factors associated with prevention of trachoma
through antibiotics, face washing, and environmental control.
Eligible study designs included peer-reviewed studies
evaluating the impact of WASH interventions on the antibiotic component of the SAFE strategy. All articles included
in the review were required to report trachoma prevalence
data before and after program implementation. Any studies
focused specifically on the outcomes of WASH interventions
as an added value to MDA with azithromycin treatments
were included. Due to limitations of monitoring and lack of
compliance with the use of tetracycline, studies distributing
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tetracycline and not azithromycin to people with active
trachoma were excluded. All impact studies, providing a
complete assessment of the SAFE strategy and its impact
on trachoma prevalence, rather than the added benefits of
the interventions to one another were additionally excluded.
Other excluded articles were those that focused on analyzing
risk factors for trachoma and providing descriptions of
trachoma and SAFE strategy through the literature-based
review.
2.2. Data Collection and Analysis. Titles and abstracts found
in the electronic databases were screened for relevancy by one
author. An external source familiar with the subject matter
was consulted when questions arose regarding a study’s eligibility. Abstracts were examined from each search result and
any abstract describing risk factors, survey results of MDA
specifically or providing a general overview of trachoma
was automatically discarded. Full copies of papers including
the combined use of key words including SAFE, WASH,
intervention, impact, added value, MDA, and azithromycin
were obtained for review. As studies were identified for
inclusion into the review, their listed references, via abstracts,
were examined for potential relevant studies. One abstract
was unavailable for review through the databases as well as
interlibrary loan; this study was excluded based on the lack of
relevancy of the title. All studies meeting the initial selection
criteria by reporting trachoma prevalence data before and
after program implementation and focusing specifically on
the outcomes of WASH interventions as an added value to
mass drug administration (MDA) of azithromycin treatments
were included. Once all titles were assessed, the relevant
articles’ full texts were retrieved and relevant information was
extracted onto a standardized form then pooled for summary
estimates of the effectiveness of the interventions on the
preventive chemotherapy programs specific to trachoma. The
data fields included on the extraction form are presented as
follows:
Author
Title
Journal
Date
Study type
Year of Baseline Survey
Sample size (𝑛) at baseline
Trachoma grading: WHO, diagnostic, or both
Specific Intervention
Specific antibiotic treatment
Population group
Age range
Number of communities
Country
Region
District
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Keyword search:
SAFE, WASH, intervention, impact, added value, MDA, and azithromycin/Zithromax

Number of

Number of articles not included: 88

articles
included:
3
Review:
14

Risk
factor: 11

Impact/
baseline
survey
results:
23

Not correct
intervention:
28

Not
trachoma
specific: 11

Abstract
not
available:
1

Figure 1: Breakdown of nonduplicated searches by reason for exclusion. Not correct intervention: either no WASH or MDA components
were mentioned or tetracycline was used rather than azithromycin.

Year of followup

3.2. Setting and Participants

Sample size (𝑛) at followup

3.2.1. Including Type of Study, Unit of Randomization, Place,
and Number. The three eligible studies were diverse in
population, region, study design, and intervention. All were
intervention studies, with a specific intention to study the
added value of the F and E components of the SAFE strategy.

Baseline prevalence
Postintervention prevalence
Effect measure
Estimate
95% confidence interval
𝑃 value.

3. Results
3.1. Results of the Search. The electronic searches yielded 156
abstracts; a total of 91 were nonrepeating. All nonrepeating
searches were screened by one author on two different
occasions. After the screening, the full texts of 10 relevant
articles were retrieved. These articles were assessed by one
author; any questions arising from the assessment of these
articles were answered by an external source specialized in
NTDs (Figure 1).
From the 10 articles retrieved, one study of Edwards
2006 did not include antibiotic treatment due to limitations
in distribution at the time of the study and therefore was
excluded from the review [7]. However, this study was
followed up again two years later by Cumberland 2008 and
with the correct inclusion criteria those results were included
in the review [13]. Two other articles by Astle 2006 and
Khandekar 2005 were not included because the antibiotic
distribution was not in the capacity of an MDA to the entire
community and was only distributed to certain individuals
during trachoma prevalence screening [6, 8, 10]. Four more
articles evaluating the comprehensive SAFE strategy Ngondi
2006, 2008 and 2010 as well as Roba 2010 were excluded
because the assessment did not specifically look at the added
value of the SAFE components to each other [8–12, 14]. The
remaining three studies were considered and accepted for
inclusion in the review (Cumberland 2008, Khandekar 2006,
and Lansingh 2010) [13–15]. A full list of reviewed excluded
studies is included in Table 1.

3.3. Types of Participants. Participants in these trials were
residents in trachoma endemic communities, in Ethiopia,
Vietnam, and Australia. No age restriction was placed on
the studies; however because active trachoma is usually
diagnosed in children under 15 years of age, the studies selflimited themselves to children below the age of 15.
Ethiopia. The Cumberland et al. 2008 study was a randomized controlled trial with staged interventions, beginning
in Guarage, Oromia, and South Welo districts of Ethiopia
between 2002 and 2003 [13]. A total of 1,722 participants, 3–9
years of age, in 37 communities were randomized into three
intervention groups and one control group. Five communities
were used in the control group and 32 received combined
intervention activities to serve as the intervention group.
Because 33 children with TI did not have follicles, the final
analysis was based on a total of 1,689 children.
Vietnam. The Khandekar et al. 2006 study was a communitybased health intervention study, whereby an intervention
community was compared to a nonintervention community,
conducted in two communities, My Thon, the intervention
village, and Xom Ngoia, the nonintervention village, in
the Gia Binh district of Vietnam [14]. In March of 2002,
children aged less than 15 years old in each community were
evaluated for inclusion in the study. Participants were chosen
by random selection. The total number of children assessed
in the analysis of the study was 911.
Australia. The Lansingh et al. 2010 study a prospective
case study, was community-based study lasting 12 months
from 2000 to 2001, including two hyperendemic Aboriginal
Australian communities [15]. Both communities assessed
children <15 years of age and were matched at baseline with
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Table 1: Excluded studies and reason for exclusion.

Author and
year
Astle et al.,
2006 [6]
Edwards
et al., 2006
[7]
Khandekar
et al., 2005
[8]
Ngondi et al.,
2006 [9]
Ngondi et al.,
2008 [10]
Ngondi et al.,
2010 [11]
Roba et al.,
2011 [12]

Reason for
exclusion

Title
Trachoma control in Southern Zambia—an international team project employing the SAFE
strategy

Spot treatment

Impact of health education on active trachoma in hyperendemic rural communities in
Ethiopia

No MDA

Active trachoma, face washing (F), and environmental improvement (E) in a high-risk
population in Oman

Spot treatment

Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change)
strategy for trachoma control in southern Sudan: a cross-sectional study
Associations between active trachoma and community intervention with antibiotics, facial
cleanliness, and Environmental improvement (A, F, E).
Estimation of effects of community intervention with antibiotics, facial cleanliness, and
environmental improvement (A, F, E) in five districts of Ethiopia hyperendemic for
trachoma
Effects of intervention with the SAFE strategy on trachoma across Ethiopia

regards to population age, gender, trachoma disease markers,
and desert climate and environment. Community 1, the
intervention community, had 86 participants and community
2, the nonintervention community, had 91. After 3 months of
intervention the total number of children under 15 years of
age reassessed was 107, after 6 months the total increased to
111 and after 12 months the total was 165.
3.4. Interventions
3.4.1. Included Types, Setting, and Duration. In the Cumberland 2008 study populations in the control villages only
received radio broadcasts as a hygiene education intervention. In addition to radio broadcast both intervention
groups received antibiotics as well as health information
in the form of information education and communication
materials (IEC). One group additionally received drama and
video. Though all intervention communities received MDA,
approximately half of the intervention communities received
azithromycin 2–5 months prior to the survey and most had
received more than one dose. The interventions were ongoing
for three years.
In the Khandekar 2006 study the nonintervention community implemented the “S” and “A” components of the
SAFE. In the intervention village, the full SAFE strategy
was implemented. The additional components specific to “F”
and E” included the provision of clean water and sanitary
latrines as well as health behavior education. Some specific
interventions included but were not limited to performances,
billboards of trachoma-control messaging, latrines, dug wells,
and water filters. The postintervention followup occurred in
2005, three years after the interventions began.
In Lansingh 2010, health and facial cleanliness promotion and azithromycin were distributed to all members of
both communities. The intervention community received an

Impact Survey
Assessed risk
factors
Impact survey
Impact survey

additional E component intervention through housing and
environmental improvements. Some of the specific improvement categories included biweekly trash collection, upgrades
in sewage and water lines, and installation of rainwater tanks.
3.5. Outcomes Measures. In the Cumberland 2008 study
outcome measures recorded in the study included prevalence
of active trachoma, TF only in one or both eyes, at baseline
and then again after intervention. The clinical diagnosis
of active trachoma was graded using the WHO-simplified
grading system. Additionally, eye swabs of all children were
taken from the right eye to detect the presence of polymerase
chain reaction (PCR) in ocular secretions C. trachomatis
deoxyribonucleic acid (DNA).
Secondary outcomes examined knowledge and behavior
related to trachoma control. These were measured through
observations and questionnaires. Observations were made
by field workers of household facilities, cleanliness, and
presence of flies in and around the houses. Questionnaires
were delivered by a locally recruited interviewer to an adult
care-giver in the home. Questions included demographic
details of both respondents and household; they were specific
to care of livestock, knowledge of health-related issues, and
practical arrangements for sanitation which were supported
by observations of field workers of beaten paths to the latrines
and human faeces in the pit.
In the Khandekar 2006 study both eyes of all family
members were examined using the WHO trachoma grading
scale; if trachoma was reported in either eye, the person was
considered to be suffering from active trachoma, TF/TI.
Secondary outcomes were assessed through close-ended
questionnaires measuring the knowledge, attitude, and practices regarding trachoma among mothers in both villages.
Questions related to attitude and practice had five grades,
from fully agree to entirely disagree, and questions related

Journal of Environmental and Public Health

5

Table 2: Summary of odds of trachoma after intervention in Cumberland 2008.
Intervention-only communities (Does not include control village)
Antibiotic treatment IEC health education video health
Antibiotic treatment IEC health education
Antibiotic treatment IEC health education video health

Age
All
Children ages: 3–9
Children ages: 3–9

Odds ratio
0.93
0.35
0.31

95% CI
0.42–2.07
0.13–.089
0.11–.089

Significance
𝑃 = 0.086
𝑃 = 0.027
𝑃 = 0.029

Table 3: Reported reduction of trachoma prevalence.
Reference

Length of study

Cumberland et al., 2008 [13]

3 years

Khandekar et al., 2006 [14]

3 years

Lansingh et al., 2010 [15]

1 year

Baseline trachoma prevalence
Control
60.7%
Overall
71.4%
Control
10.2%
Intervention
13.8%
Control
49.6%
Intervention
47.7%

to knowledge included common symptoms of trachoma,
blinding complications of trachoma, methods of methods
of prevention, water sources for drinking and face washing,
and the advantages of a sanitary latrine. Evaluation of water
and sanitation status was done by a water engineer who
quantitatively and qualitatively recorded the status of the
water, latrine, and other sanitation facilities in and around the
house.
In the Lansingh 2010 study baseline measures of trachoma
prevalence, facial cleanliness, and nasal discharge were measured. Assessments of trachoma and facial cleanliness were
made at 3, 6, and 12 months before intervention. Clinical
assessment of trachoma was conducted by a single examiner
using the WHO-simplified grading system. Active trachoma
was defined as the presence of TF or TI.
Secondary measures were taken by Aboriginal Health
workers (AHW) trained to assist with examinations, promote
health education when participants visited clinics for any reason, and conduct the health education campaign at the home
level. An active health education campaign with emphasis
on facial cleanliness was instituted in schools, primarily
facilitated by teachers and personnel from the Nganampa
Health Council.
Absolute facial cleanliness was defined as the absence
of ocular and nasal discharge. Partial facial cleanliness was
defined as having either ocular or nasal discharge, but not
both. A “dirty face” had both ocular and nasal discharge; the
quality of discharge was also recorded as clear, abundant, or
mucopurulent. Health Living Practices (HLP) were measured
by survey at baseline and approximately 8 months after
intervention, to be considered passing, eight of the nine HLP
must be met.
3.6. Effects of Intervention. Due to the statistical, methodological, and clinical heterogeneity of studies conducting a
meta-analysis was not considered appropriate and a narrative
summary of the results is presented.
3.7. Primary Outcome: Prevalence of Active Trachoma. In
Cumberland 2008 study, the overall prevalence (standard

After intervention
54.5%
35.6%
5.54%
02.3%
30.0%
21.2%

Percent reduction
10.0%
50.0%
46.1%
83.0%

Added value

59.2%

deviation: SD) of active trachoma in the 37 communities were
71.4% (17.6) in 2002 and 35.6% (17.4) in 2005, illustrating
around a 50% reduction in prevalence. The cluster summarized prevalences (SD) of active trachoma estimated in the
control communities were 60.7% (12.1) in 2002, 55.1% (12.5)
in 2003, and 54.5% (20.3) in 2005. The reduction in the intervention community was found statistically significant but the
reduction in the control communities, only receiving radio as
an intervention, was not statistically significant (𝑃 = 0.692).
The odds of trachoma in the intervention communities, after
intervention, are summarized in Tables 2 and 6.
In communities receiving azithromycin and video educational interventions, a reduction in the odds of active
trachoma did not occur. However, after adjustment for age,
results suggested an almost 70% reduction in odds of active
trachoma in children living in communities that received
antibiotic treatment and IEC health education materials and
those in communities that additionally received the video
health messages.
In Khandekar 2006 study, the village with the added value
of the F and E components experienced a decrease in the
prevalence of trachoma, in children <15 years, from 13.8% at
baseline to 2.3% after intervention, a prevalence difference
of 11.53%. Prevalence of active trachoma dropped as well in
children <15 years from the nonintervention community (SA
only) from 10.2% to 5.54%, an absolute difference of 4.7%.
The additional absolute decline of trachoma infection due to
F and E in children <15 years of age was 6.8%.
The decline of active trachoma in the nonintervention
village was considered to be due to the impact of the S and A
components. When the impact of the F and E strategy under
the circumstances of this study was controlled for, a decline
of 59.2% in active trachoma was attributed to the additional
activities of the F and E components of the SAFE strategy in
the intervention community. (6.83/11.53 ∗ 100 = 59.2%).
In Lansingh 2010 study a reduction in prevalence of trachoma was observed three months after antibiotic administration. At that time, the active trachoma prevalence reduced
from 47.7% to 21.2% in the intervention community and from
49.6% to 24.2% in the nonintervention community. By 12
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Table 4: Reported increase in primary trachoma-related KAP.
Reference

Baseline KAP

Secondary outcome measure

Cumberland et al., 2008 [13]

Knowledge of trachoma

Khandekar et al., 2006 [14]

Knowledge of trachoma

Lansingh et al., 2010 [15]

Facial cleanliness
(absolutely clean 1-9 years)

After intervention KAP

Overall

45.0%

Control
Intervention
Control
Intervention

38.0%
45.4%
23.5%
16.5%

Control
Intervention 1
Intervention 2

82.9%
85.6%
96.0%
78.0%
99.3%
57.0%
85.0%

Percent Increase
48.0%
47.0%
54.0%
51.0%
54.0%
59.0%
81.0%

Table 5: Methodological evaluation of the quality of included studies.
Quality of evidence
Selection bias
Random sampling
Sample size
Comparability
Compliance
“A” coverage (over 80%)
“F” and “E”
Confounders
Descriptive variables
Climate
Masking
Applicability

Cumberland et al., 2008 [13]

Khandekar et al., 2006 [14]

Lansingh et al., 2010 [15]

Yes
N/A
No

Yes
Yes
Yes

Yes
No
Yes

Yes
Yes

N/A
Yes

No
Yes

No
No
No
Yes

Yes
Yes
Yes
Yes

No
Yes
No
No

Table 6: Summary of included studies and health measures.
Paper

Intervention

Control: only radio
MDA and radio
MDA, radio and
information
Cumberland
education and
et al., 2008
communication
[13]
materials (IEC)
MDA, IEC, and
community video and
drama
Khandekar
Water supply
et al., 2006
Sanitation supply
[14]

Lansingh
et al., 2010
[15]

Environmental
enhancements
Water supply

Country and
population

Study
quality

Health
outcome

Age group

Measure

Ethiopia
1689

Good

Trachoma

3–9 years

Change in
prevalence

Vietnam
911

Great

Trachoma

<15

Change in
prevalence

Australia
111

Poor

Trachoma

<15

Change in
prevalence

Statistical test
OR 0.35 radio, MDA,
IEC
CI 0.13–0.89
P value: 0.027
OR 0.31 radio, MDA,
IEC, and video
CI 0.022–0.89
P value: 0.029

𝑋2 = 9.1
community 1
P value: 0.003
𝑋2 = 8.1
community 2
P Value: 0.005
OR 0.99
CI 0.93–1.05
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months it rose to 30% in the nonintervention community
but remained stable in the intervention community. The
reduction in trachoma prevalence between preintervention
and 12 months after intervention was significant for both
communities:
𝑋2 = 9.1 Intervention Community (A, F, E) 𝑃 = .003.
𝑋2 = 8.1 Nonintervention Community (A, F) 2𝑃 =
.005.
However, there was no significant difference in the
trachoma prevalence between the two communities at any
examination.
Table 3 illustrates a synopsis of results in change of
trachoma prevalence.
3.8. Secondary Outcome
3.8.1. Changes in Knowledge, Attitude, and Practice. In the
Cumberland 2008 study, there was no evidence of a difference
in awareness of trachoma and trichiasis across intervention
arms; however, the overall community-summarized awareness was greater than 80%. Since the initial baseline survey
in 2002 and the follow-up survey in 2003, householders
reported knowing at least one trachoma prevention method
as compared to not knowing any in communities receiving
printed and video health education.
In the Khandekar 2006 study, the knowledge, attitude and
practices among the mothers of both villages at baseline and
at the end of two years were compared. An improvement in
knowledge of the subcomponents of trachoma prevention,
including knowledge of trachoma, among the mothers in
the intervention village was greater than among the mothers
in the nonintervention village. However, the attitude and
practices of trachoma control continued to be at the same
level among the mothers of both villages.
The Lansingh 2010 study did not measure knowledge,
attitude and practices as a secondary outcome for trachoma
knowledge; instead, the study looked specifically at facial
cleanliness in regards to a measure of the added benefit of
the “E” intervention. Postintervention followup at 12 months
showed a greater percentage of clean faces and less prevalence
of nasal discharge in the non-“E” intervention community.

4. Discussion and Conclusion
4.1. Trachoma Prevalence. Poverty creates a major barrier to
gaining access to clean water, perpetuating the link between
trachoma, lack of water, sanitation, hygiene education, and
economic development [26]. According to the WHO, “the
availability of clean water is a prerequisite to the sustainable
growth and development of communities around the world”
[27]. The conditions of poverty and inequality perpetuating the prevalence of trachoma and unsafe water and
sanitation continue claiming lives, destroying livelihoods,
and compromising prospects for economic growth [26].
Economic stability affects poor living conditions increasing
the need for environmental interventions in trachoma control
[22]. If all associated factors important to transmission of
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trachoma are not addressed, then a sustainable program
cannot be created and the disease is likely to recur [28]. As
a result, sustainable control and elimination strategies for
trachoma are especially reliant on the development of the
overall infrastructure of a nation through the integration of
collaborative efforts between the health and WASH sectors
[29]. This review tried to recognize the added value of WASH
factors to the “A” component of the SAFE strategy in order
to advocate for collaboration between sectors for trachoma
control ultimately elevating the continued cycle of poverty
propagated by trachoma [20].
The articles included in the review observed a decrease
in prevalence of trachoma over the entire length of study.
Although the magnitude of effect varied, the decline in
trachoma was apparent in all villages, both control and
intervention for all three studies reviewed in the control
communities. Where no additional interventions took place,
the decrease was due to the natural improvements in socioeconomic status [30]. Even without intervention, change in
village demographics and employment brought additional
income resulting in access to water and sanitation facilities
as well as increased access to mass media through additional
purchasing of radio and TV.
4.2. Primary Outcome. In the Cumberland 2008 and Khandekar 2006 study, the decrease in trachoma prevalence was
significant not only between the pre- and postinterventions
but between the intervention and nonintervention communities. This suggests that adding water, sanitation, and hygiene
education interventions to the ongoing mass antibiotic distribution had a significant impact on reducing the prevalence
of trachoma. In contrast, however, the Lansingh 2010 study
found a significant decline between pre- and postintervention
but not between villages. The study was unable to determine
if the “E” environmental component added significant value
to the SAFE strategy between the two villages studied. There
are many reasons for the variability in results between these
studies including quality of study design and coverage rates
of antibiotic.
In Cumberland 2008 study, the decline in prevalence
was attributed to treatment of azithromycin; however, the
other components studied as well reported added value to
the decline of trachoma prevalence, around a 50% decrease
from baseline to postintervention followup. The study suggested that health education and community based programs
appeared to have additional positive results on the “A” component of SAFE, but percentage prevalence decreased because
of the AFE components were not separately calculated. The
Khandekar 2006 study did calculate the added benefit and
found that providing the “F” and “E” components in addition
to the “S” and “A” contributed to a nearly 60% decline in active
trachoma prevalence. These components were additionally
responsible for the decline of more than one-third of the
active trachoma prevalence in children, confirming the association of water and sanitation improvement with the decline
of active trachoma.
In the Lansingh 2010 case study, the “A” and “F” components of the SAFE strategy interventions significantly
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reduced the prevalence of trachoma in both communities.
Though the communities achieved significant reductions
in trachoma prevalence between preintervention and 12month postintervention assessments, there was no evidence
that the specific environmental changes implemented in
the intervention community had any additional impact to
the improvement of facial cleanliness and antibiotic distribution. The reason for the lack of significant change was due to
the small sample size, low antibiotic coverage, and problems
with the overall study design.
4.3. Secondary Outcome
4.3.1. Knowledge, Practice, and Attitude (KPA). Changing
deep-rooted cultural behaviors is difficult; however, if effective, it creates a collective and sustainable awareness [31].
In Cumberland 2008 study, the percentage of householders
surveyed who knew about trachoma was 45%; of those only
20% knew about trachoma risk factors and treatment options.
Previously, the emphasis for prevention and treatment methods for trachoma focused on traditional beliefs and practices.
It was reported that in 2003 and 2005, a shift occurred away
from traditional beliefs to a better understanding of trachoma
and the SAFE strategy as a preventative method and cure.
In the Khandekar 2006 study, a notable improvement
in the KAP of mothers after two years was demonstrated.
The reason for the improvement was due to the leveraging
of organizations within the village in addition to passive
advocacy through mass media. The model included using
women’s associations and involving school teachers to educate the community. Lansingh 2010, did not measure KAP as
an outcome of the added benefit of the “E” component.
4.3.2. Facial Cleanliness and Nasal Discharge. In the Lansingh
2010 study, contrary to the assumed outcome, the nonintervention community which received only the “A” and “F”
components of SAFE performed better than intervention
community, which had the additional “E” component, in
regards to facial cleanliness and nasal discharge. These secondary outcomes, however, were not easily correlated to the
small difference in prevalence of trachoma.
4.4. Quality of the Evidence. Establishing a reliable study
design is crucial in providing quality evidence; yet it is always
a challenge. To minimize risk of bias, a study has to establish
appropriate sample size, randomize participants, control for
confounders, and select controls to match cases [9]. In this
review, the study with the most comprehensive description of
these elements was by Khandekar 2006. In the Cumberland
2008 and Lansingh 2010 studies it was unclear if risk of
selection/sampling and confounding bias was accounted for
or if it was simply omitted in the reporting stage. In regards
to this review, the analysis was conducted with information
provided only by the respective articles.
4.5. Selection Bias. Of the three studies reviewed, one study,
the Lansingh 2010 study, did not mention randomizing
participants. The Cumberland 2008 study stated that the
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participants and communities were randomly chosen. Delays
with distribution prevented the study to stick to the original
randomization schedule and local NGO’s were responsible
for distribution of interventions on their own schedule. The
details of the original design were reported in the 2003 study
published in 2006. The Khandekar 2006 study also stated
random selection. The researchers also tried to minimize
systematic error by having an appropriately sized population
of all ages. In contrast, the Lansingh 2010 study did mention
that the effect size (which at the time had not been tested
for the E component) was beyond the detectable level since
the number of children surveyed in both communities was
relatively low.
4.6. Comparability. In the Cumberland 2008 study, the communities used in the study were randomly selected from
different zones within the trachoma control program areas.
There was, however, no additional information offered about
the comparability of these villages. In the Khandekar 2006
and Lansingh 2010 studies the studied villages were chosen
specifically because of comparable characteristics. In the
Khandekar 2008 study the villages had similar population
profiles and sanitation status; only the water sources differed.
only the water sources differed. In order to prevent crosscontamination between groups, study villages were in separate communities with five other villages between them and
markets and educational centers were also different. In the
Lansingh 2010 study, the two communities were matched in
general at baseline with regard to population age, gender,
trachoma disease markers, desert climate and environment,
although mobility was much higher in the intervention
community.
4.7. Compliance
4.7.1. Azithromycin Coverage. During mass drug administration (MDA) of azithromycin 100% of the eligible population
is targeted for treatment through preventive chemotherapy. Coverage results above 90% are considered reliable in
achieving intervention outcomes and reducing the chance for
recurrence of trachoma [20]. In the Cumberland 2008 study,
92% coverage of azithromycin distribution was reported. The
Lansingh 2010 study, only achieved an antibiotic coverage of
73% and 55% in communities 1 and 2, respectively, and the
Khandekar 2006 study did not specify MDA coverage rates.
4.7.2. Compliance with Water and Sanitation. Compliance of
the “F” and “E” components was measured by frequency of
face washing, latrine use, and other sanitation interventions.
In the Cumberland 2008 study, householders in intervention villages reported that additional family members used
pit latrines for defecation, and 60–70% of all householders
in each arms of the study reported good rubbish disposal
practices. In intervention communities there was a 15%
decrease of community-reported prevalence of animal faeces
in the immediate proximity to the house.
In the Khandekar 2006 study access to a sanitary latrine
and use by all members of the family (including children)
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improved in both villages in two years but it was better in the
intervention village than in nonintervention village. Additionally, fly density was significantly lower in the intervention
village than in the nonintervention village at the end of two
years:
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observer bias. Though the study was unable to mask the
field staff that assessed the status of the water and sanitation,
the results in the houses of the intervention village and the
nonintervention village were coded and given to an external
evaluator.

𝑋2 = 270, df = 2 𝑃 = 0.00001.
Water facilities improved in both villages after two years
of intervention. However, in the nonintervention village the
quality of water and cleanliness around the water source
remained unsatisfactory in about one-third of the houses.
In the Lansingh 2010 study, baseline prevalences of an
absolutely clean face in the intervention community were
30% and 23% in the nonintervention community while those
of a dirty face were 64% and 58% respectively (difference
not significant). After the intervention, in children less than
10 years, no nasal discharge was observed on 30% of faces
in the intervention community compared to 12% in the
nonintervention community:
𝑋2 = 5.7 𝑃 = 0.02.
The intervention community showed positive postintervention Nganampa Health Council (NHC) survey results
with substantial gains in washing clothes/bedding (+52%
change) and removing waste safely (+14% change) following
the intervention; however, the majority of houses did not
reach a change in outcomes in most categories.

4.10. Applicability. Factors affecting generalizability of methods were different for each study and a summary of methodological elements is presented in Table 4. The Cumberland
2008 study found additional value to health education yet
acknowledged that educational campaigns are time consuming and produce variable results. Additionally, the community mass media intervention used does not present an
effective method of ensuring sustainable prevention in hyperendemic rural populations which may have limited access to
mass media including radios. Control for sampling bias was
considered in the study design, even though it was reported
in a previous article. The methods used in the Khandekar
2006 study, including leveraging local organizations with
skills of social marketing and community commitment, could
be promoted in other rural areas of developing countries
as a form of trachoma control. The Lansingh 2010 study,
however, lacked complete applicability of evidence due to the
previously mentioned absence of a reliable and valid study
design (Table 5).
4.11. Authors’ Conclusions

4.8. Confounding. In order to minimize misrepresentation
of the overall effects of the added value of the WASH
components, the studies controlled for confounding variables known to affect the prevalence of trachoma. In the
Khandekar 2006 study, the following variables were collected
and controlled for age, gender, educational level, occupation,
level of poverty, and access to mass media. While active
trachoma rates were projected for the study population, the
rates by age and gender were adjusted to compensate for
the differential representation of subgroups. The effects of
these confounders were found to be minimal in this study.
In both Khandekar 2006 and Lansingh 2010 studies, climate
was considered a possible confounder. It was observed that
trachoma prevalence was higher during certain seasons. For
this reason both studies planned prevalence assessments at
similar times and in similar conditions.
Though the Lansingh 2010 study accounted for climate,
other potential confounders were not controlled for. The
levels of dust and flies were not assessed in the nonintervention community, and the houses were not surveyed
before or after the intervention. By not controlling for these
confounders, there was no valid information of the number
of houses that might have passed the various HLP categories
in the nonintervention community, and whether the A/F
interventions there made any difference. Cumberland made
no mention of controlling for confounders in the 2008 study
design.
4.9. Masking. The Khandekar 2006 study was the only
study to specifically mention masking as a way to minimize

4.11.1. Implication for Practice. In order to eliminate blinding
trachoma as a public health problem, recurrence of the active
form of the disease must be interrupted before repeated
scarring leads to trichiasis. The antibiotic component of
the SAFE strategy offers an immediate treatment option;
however it is not considered sustainable [19]. Combining
the “F” and “E” components strengthens the prevention and
control of trachoma; yet little research has been done on the
actual amount of added value the individual “A,” “F,” and “E”
components have to one another. After thorough review of
the literature, all articles showed the “F” and “E” components
provided significant value to the overall decrease of prevalence of active trachoma. However, due to study limitations
and an insufficient number of articles on the subject, it is
not possible to determine the added benefit of the “F” and
“E” components to the mass distribution of azithromycin
as the “A” component. Additional research in identifying
the added value of WASH on decreasing trachoma infection
would facilitate advocacy efforts and collaboration between
trachoma programs with WASH groups to reach program
goals. Establishing the added value for WASH components
would encourage integration between appropriate partners
in order to pool resources and use coordinated sites and
indicators allowing both WASH and trachoma programs to
amplify the impact of their interventions.
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